Comment on: New therapeutics for ANCA-associated vasculitis: 10 years devoted to lessen toxicity by Rossi et al

Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):186. doi: 10.55563/clinexprheumatol/rym1op. Epub 2021 Mar 22.

Authors

Gioacchino Li Cavoli¹, Calogera Tortorici², Luisa Bono², Carlo Giammarresi², Giacomo Ferrantelli², Tancredi Vincenzo Li Cavoli², Angelo Ferrantelli²

Affiliations

¹ Nephrology Dialisys Renal Transplantation, Civic Hospital Palermo Italy. gioacchinolicavoli@libero.it.
² Nephrology Dialisys Renal Transplantation, Civic Hospital Palermo Italy.

PMID: 33769260
DOI: 10.55563/clinexprheumatol/rym1op

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
Antibodies, Antineutrophil Cytoplasmic
Humans

Substances

Antibodies, Antineutrophil Cytoplasmic